Visionary Wealth Advisors Purchases New Position in Danaher Corporation $DHR

Visionary Wealth Advisors purchased a new stake in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 89,793 shares of the conglomerate’s stock, valued at approximately $64,655,000. Danaher accounts for about 2.6% of Visionary Wealth Advisors’ portfolio, making the stock its 9th biggest position.

Several other hedge funds have also recently bought and sold shares of the stock. BlackRock Inc. acquired a new position in shares of Danaher in the second quarter valued at approximately $10,492,520,000. Norges Bank acquired a new stake in Danaher during the 4th quarter worth approximately $2,177,106,000. Generation Investment Management LLP acquired a new stake in Danaher during the 2nd quarter worth approximately $1,287,949,000. Flossbach Von Storch SE bought a new stake in Danaher in the 2nd quarter valued at $747,260,000. Finally, Bank of New York Mellon Corp acquired a new position in Danaher in the 2nd quarter valued at $712,875,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

DHR has been the subject of a number of research reports. Guggenheim dropped their target price on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Wells Fargo & Company decreased their price target on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Piper Sandler assumed coverage on shares of Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective for the company. Finally, Stifel Nicolaus decreased their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Stock Performance

NYSE:DHR opened at $215.18 on Tuesday. The company has a market cap of $151.27 billion, a price-to-earnings ratio of 38.22, a PEG ratio of 2.72 and a beta of 0.78. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock has a fifty day moving average price of $196.49 and a 200-day moving average price of $192.39.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue was up 5.5% on a year-over-year basis. During the same quarter last year, the business earned $0.77 earnings per share. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.